This is a StreetInsider.com Premium Only Page

VBI Vaccines (VBIV) – Management Changes

Apr 4, 2023 08:02 AM VBI Vaccines (VBIV) Announces Increased Focus on Hepatitis B, Organizational Changes, and 1-for-30 Reverse Stock Split

Jul 12, 2022 08:00 AM VBI Vaccines (VBIV) Appoints John Dillman as Chief Commercial Officer

Apr 11, 2019 04:08 PM

Jan 16, 2019 08:01 AM

Aug 15, 2018 08:03 AM

Jan 26, 2018 04:27 PM